Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-11-3
pubmed:abstractText
Endometrial cancer is the most common gynecological cancer. Estrogen-dependent endometrioid carcinoma is the most common type of endometrial cancer, and alterations in the expression of PTEN and K-ras have been associated with this disease. To study the roles of Pten and K-ras in endometrial cancer, we generated Pten ablation and oncogenic K-ras mutation in progesterone receptor positive cells (PR(cre/+)Pten(f/f)K-ras(G12D)). Double mutant mice dramatically accelerated the development of endometrial cancer compared to a single mutation of either gene. Histological analysis showed that all of the 1-month old double mutant female mice developed endometrial cancer with myometrial invasion. The expression of PR was downregulated in double mutant mice compared to a single mutation of either gene which resulted in decreased suppression of estrogen signaling. Therefore, these results suggest a synergistic effect of dysregulation of the Pten and K-ras signaling pathways during endometrial tumorigenesis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-10727250, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-11174845, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-11190805, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-11323676, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-11389093, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-11857804, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-11981029, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-15093544, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-15272277, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-15289454, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-15682389, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-15806138, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-15845746, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-16585156, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-16688764, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-17028294, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-171569, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-17785917, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-17964232, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-18281487, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-18317228, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-18632614, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-2141316, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-2667965, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-4683406, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-4715727, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-8234270, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-8380547, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-8692240, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9090379, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9187108, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9389917, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9635567, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9648591, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9697695, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9699651, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884980-9721853
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:issn
1687-8450
pubmed:author
pubmed:issnType
Print
pubmed:volume
2010
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
139087
pubmed:year
2010
pubmed:articleTitle
The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action.
pubmed:affiliation
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article